ADMA Stock: Why It Fell Today

08:09am, Thursday, 21'st Oct 2021
The stock price of ADMA Biologics Inc (NASDAQ: ADMA) fell by over 8% pre-market today. This is why it happened.
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 18, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufactu
The FDA has approved ADMA Biologics Inc's (NASDAQ:ADMA) in-house aseptic fill-finish machine, the VanRx SA25. Related Content:   ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Fa
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufactu
Last week, there were three significant developments with respect to ADMA. The market has taken these events to be bearish for ADMA's outlook, with the stock selling off this week.
The shares of ADMA Biologics Inc (NASDAQ: ADMA) increased by over 15% pre-market. This is why it happened.
RAMSEY, N.J. and BOCA RATON, Fla. and MARYVILLE, Tenn., Aug. 16, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated
ADMA Biologics: Feeling Bullish After Encouraging Q2 Earnings Report
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2021 Results - Earnings Call Transcript
Adma Biologics (ADMA) delivered earnings and revenue surprises of 0.00% and 7.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over Second Quarter 2020
RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE